Selig Zises sold $1.6M of ESQ
director at Esquire Financial Holdings, Inc.. 20,000 shares at an average of $77.59, traded Feb 28, 2025, filed Mar 4, 2025.
Score components
- +15RoleDirector
- +25Trade size$1.6M at market
- +10Share of holdings soldSold 36% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.2%, 3m +22.3%, 6m +30.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-25-006023, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 28, 2025 | SOpen-market sale Common Stockindirect: By profit sharing plan | -1,000 | $76.70 | $77k | 54,501 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stockindirect: By profit sharing plan | -1,500 | $76.97 | $115k | 53,001 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stockindirect: By profit sharing plan | -1,500 | $77.20 | $116k | 51,501 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stockindirect: By profit sharing plan | -1,500 | $77.30 | $116k | 50,001 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stockindirect: By profit sharing plan | -1,500 | $77.60 | $116k | 48,501 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stockindirect: By profit sharing plan | -1,500 | $77.65 | $116k | 47,001 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stockindirect: By profit sharing plan | -1,000 | $77.67 | $78k | 46,001 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stockindirect: By profit sharing plan | -3,000 | $77.70 | $233k | 43,001 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stockindirect: By profit sharing plan | -1,500 | $77.75 | $117k | 41,501 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stockindirect: By profit sharing plan | -4,500 | $77.80 | $350k | 37,001 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stockindirect: By profit sharing plan | -1,500 | $78.32 | $117k | 35,501 | Mar 4, 2025 |
Related signals
Other insiders at Esquire Financial Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | ESQsell Esquire Financial Holdings, Inc. | Andrew C Sagliocca Vice Chairman, President & CEO | $1.2M 10,000 shares | -3% | |
| 31Weak | ESQsell Esquire Financial Holdings, Inc. | Robert Mitzman director | $389k 3,000 shares | -2% | |
| 68Notable | Esquire Financial Holdings, Inc. | Selig Zises director | $3.2M 30,000 shares | -143% | |
| 36Weak | Esquire Financial Holdings, Inc. | Richard T Powers director | $242k 2,308 shares | -4% | |
| 47Moderate | Esquire Financial Holdings, Inc. | Joseph Melohn director | $900k 9,000 shares | -7% | |
| 68Notable | Esquire Financial Holdings, Inc. | Selig Zises director | $1.7M 17,000 shares | -58% | |
| 48Moderate | Esquire Financial Holdings, Inc. | Joseph Melohn director | $1.2M 12,326 shares | -8% | |
| 38Weak | ESQsell Esquire Financial Holdings, Inc. | Selig Zises director | $477k 5,000 shares | -16% | |
| 65Notable | Esquire Financial Holdings, Inc. | Selig Zises director | $1.1M 13,000 shares | -37% | |
| 43Moderate | Esquire Financial Holdings, Inc. | Kevin C Waterhouse director | $252k 3,000 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.